Hypothalamic control of growth hormone (GH) secretion in type i diabetic men: Effect of the combined administration of gh-releasing hormone and hexarelin, a novel GHRP-6 analog

Insulin dependent (type I) diabetic patients show abnormal growth hormone (GH) secretion. Hexarelin is an analog of GHRP-6 which releases GH in part via somatostatin inhibition. The aim of our study was to evaluate the effects of hexarelin and GHRH, administered either alone or in combination, on GH...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Endocrine research 1996-01, Vol.22 (2), p.159-174
Hauptverfasser:	Giustina, A., Desenzani, P., Perini, P., Deghenghi, R., Bugari, G., Wehrenberg, W. B., Giustina, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Blood Glucose - metabolism Diabetes Mellitus, Type 1 - physiopathology Drug Synergism Growth Hormone-Releasing Hormone - administration & dosage Growth Hormone-Releasing Hormone - pharmacology Human Growth Hormone - secretion Humans Hypothalamus - physiopathology Kinetics Male Oligopeptides - administration & dosage Oligopeptides - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!